Danaparoid and renal impairment Patient Reports February 12, 2012

Danaparoid Side Effects Report #4845868-X
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Nov 22, 2005. Male patient, 75 years of age, was diagnosed with thrombocytopenia, haemodialysis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: colon cancer, haemodialysis, postoperative infection, renal impairment, septic shock, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, ENOXAPARIN, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5115444-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 13, 2006. Female patient, 89 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastric haemorrhage, hypertension, pneumonia , renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, GABEXATE MESILATE, DOPAMINE, CARPERITIDE, INSULIN, FUROSEMIDE, MIDAZOLAM, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5046810-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, hepatic function abnormal, pneumonia , renal impairment, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5113491-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, blood lactate dehydrogenase increased, condition aggravated, hepatic function abnormal, malnutrition, platelet count decreased, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5030651-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, hepatic function abnormal, malnutrition, postoperative infection, renal impairment, wound haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5047255-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cardiac tamponade, condition aggravated, infection , leukaemia, liver disorder, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, AMIKACIN SULPHATE, PIPERACILLIN, IDARUBICIN, CYTARABINE, MEROPENEM, TOBRAMYCIN, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #4990412-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cardiac tamponade, infection , liver disorder, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, AMIKACIN SULPHATE, PIPERACILLIN, IDARUBICIN, CYTARABINE, MEROPENEM, TOBRAMYCIN, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5084705-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 03, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5097842-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 24, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatinine increased, pulmonary alveolar haemorrhage, renal impairment, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5033184-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5124726-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5024837-3
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on June 01, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, sepsis , septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5153401-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 57 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, hepatic function abnormal, multi-organ failure, neoplasm malignant, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, NAFAMOSTAT MESILATE, DOPAMINE, OMEPRAZOLE, CEFOZOPRAN HYDROCHLORIDE, ANTITHROMBIN III, ULINASTATIN. Patient died.

Danaparoid Side Effects Report #5024840-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, renal impairment, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.


Danaparoid Side Effects Report #5030494-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, renal impairment, sepsis , thermal burn. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5116967-2
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 19, 2006. Male patient, 74 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, condition aggravated, disseminated intravascular coagulation, haematuria, hepatic function abnormal, malnutrition, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE, TEICOPLANIN. Patient was hospitalized. Patient recovered.